DYOR.
We can't start to form a good picture of what each of the Pillars is worth, looking at revenues underpinning peer buyout transactions.
(there a problems with these comparisons though - will explain below)
Pillar 3:
Pillar 2:
- AML peak sales USD $1B (Forty Seven)
- Ovarian Cancer peak sales USD $2B (Tesaro)
Pillar 1:
- Breast Cancer peak sales USD $4.7B (Immunomedics)
- The problem with this comparison is Immunomedics is focused on Triple Negative Breast Cancer (forgive the link), which is only about 1/4 to 1/3rd of the indication that RACE are pursuing.
Adjusting for comments above:
- Buyouts for various inhibitors ranging from USD $1B to USD $6B peak sales.
- The problem with this comparison is that the wide range of indications under FTO could eventually be worth around the USD $24.3B peak sales of Keytruda ( particularly if RACE's theory of Bisantrene being able to reduce resistance to PD-1 inhibitors works out to be proven ) ... dual effect of growing the market for PD-1 inhibitors and in parallel supporting rapid ramp up of sales of Bisantrene. This is notwithstanding the other opportunities where knockdown of FTO with Bisantrene could reduce resistance to other inhibitors such as TKI inhibitors.
- AML peak sales USD $1B
- Ovarian Cancer peak sales USD $2B
- Breast Cancer peak sales USD $14.1 ( 3 x USD $4.7B )
- FTO peak sales USD $24.3B
- Total = USD $41.4B peak sales
Mind boggling numbers but at average buyout multiple of say 5.6x that's theoretical value of USD $231B ( obviously RACE will never get the opportunity to prove up all these opportunities in trials and RACE will probably get taken out for 5% to 10% of this value ).
- Forums
- ASX - By Stock
- RAC
- RAC - Charts & Price Action
RAC - Charts & Price Action, page-4009
-
- There are more pages in this discussion • 18,725 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
0.055(3.59%) |
Mkt cap ! $270.1M |
Open | High | Low | Value | Volume |
$1.56 | $1.60 | $1.53 | $79.91K | 51.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 25 | $1.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 23239 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 25 | 1.550 |
1 | 493 | 1.545 |
3 | 9250 | 1.510 |
4 | 14647 | 1.505 |
8 | 70897 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 23239 | 1 |
1.650 | 17029 | 2 |
1.690 | 6570 | 3 |
1.695 | 7731 | 1 |
1.720 | 632 | 1 |
Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non Executive Director
Simon Kidston
Non Executive Director
SPONSORED BY The Market Online